Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: What are we to do?

What are we to do?

posted on Apr 25, 2008 12:03PM

Can we really do anything of any substance? Are we just along for the ride.

Does anyone really think us shareholders can put/afford a legal team as strong as Tpl?

Do we send another letter? What does that really accomplish.

Brian, as bright and devoted as he is, was unable to affect the board.

I am wondering why TPL isn't making a move yet. Why would they wait until the patent re-evaluations is complete. Then the sp may move beyond what they can control.

Posters have posted that the SEC is under staffed/funded and would be a dead end street.

Choices: Sell for a substantial loss or See where this scary ride leads.

All IMO

Share
New Message
Please login to post a reply